Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
34 hedge funds and large institutions have $10M invested in Psychemedics Corporation in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 4 closing their positions.
3% less funds holding
Funds holding: 35 → 34 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
30% less capital invested
Capital invested by funds: $14.4M → $10M (-$4.39M)
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$112K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$61.3K |
| 3 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
+$22.4K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
+$14.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.16M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$130K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$114K |
| 4 |
Renaissance Technologies
New York
|
-$66.8K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$65.8K |
PMD Hedge Fund Activity: Q3 2020 in Review
34 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2020, worth a combined $10M — down 30% from $14.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PMD and 3 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 4 added.
The largest buyer was Invenomic Capital Management, adding an estimated $112K. The largest seller was Kennedy Capital Management, cutting an estimated $1.16M.
- 34 institutional investors held Psychemedics Corporation (PMD) as of Q3 2020, down from 35 in Q2 2020.
- Funds reported $10M of Psychemedics Corporation stock for Q3 2020, down 30% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q3 2020 and 4 closed out, a net change of -1 holder.
- The largest Psychemedics Corporation buyer in Q3 2020 was Invenomic Capital Management, an estimated $112K added.
- The largest Psychemedics Corporation seller in Q3 2020 was Kennedy Capital Management, an estimated $1.16M sold.
Based on aggregated 13F filings for Q3 2020.